Comparison of original and modified Academic Research Consortium for High Bleeding Risk definitions in real-world

Kotaro Takahashi1, Katsuya Miura1, Yuki Shima1

  • 1Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.

Journal of Cardiology
|March 14, 2022
PubMed

Insights

Simplified High Bleeding Risk (S-HBR) effectively predicts bleeding after percutaneous coronary intervention, similar to the original ARC-HBR definition. Japanese High Bleeding Risk (J-HBR) is also useful for long-term bleeding risk prediction.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Risk Stratification

Background:

  • High Bleeding Risk (HBR) is crucial in percutaneous coronary intervention (PCI).
  • Existing definitions include the Academic Research Consortium for High Bleeding Risk (ARC-HBR).
  • Simplified HBR (S-HBR) and Japanese HBR (J-HBR) have been proposed to refine HBR assessment.

Purpose of the Study:

  • To compare the diagnostic values of ARC-HBR, S-HBR, and J-HBR.
  • To evaluate the predictive accuracy of different HBR definitions for major bleeding events.
  • To assess the utility of these definitions at short-term (1 year) and long-term (7 years) post-PCI.

Main Methods:

  • Retrospective analysis of 3430 patients undergoing PCI with second-generation drug-eluting stents (2010-2013).
  • Evaluation of major bleeding and ischemic events.
  • Comparison of diagnostic values using receiver-operating characteristic (ROC) curves.

Main Results:

  • Incidence of major bleeding at 7 years: ARC-HBR 10.6%, S-HBR 10.7%, J-HBR 10.0%.
  • J-HBR showed lower diagnostic value than ARC-HBR at 1 year (C-statistics 0.64 vs. 0.68).
  • S-HBR and J-HBR demonstrated comparable diagnostic values to ARC-HBR for overall bleeding risk prediction.

Conclusions:

  • Simplified HBR (S-HBR) is a valuable tool for predicting both short- and long-term bleeding risk, comparable to ARC-HBR.
  • Japanese HBR (J-HBR) is also effective for predicting long-term bleeding risk in patients undergoing PCI.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
187
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
278